Skip to content

Evaluation of current emergency department triage methods during a flu pandemic

PAndemic INfluenza Triage in the Emergency Department (PAINTED)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN56149622
Enrollment
20500
Registered
2012-07-19
Start date
2012-10-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pandemic influenza Infections and Infestations Influenza due to certain identified influenza virus

Interventions

Emergency department staff will be provided with a standardised assessment form. This form acts not only as a data collection form, for the purposes of the research, but also as a clinical record stor

Sponsors

Sheffield Teaching Hospital (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will include all adults and children presenting the emergency department of the participating hospitals with suspected pandemic influenza during the peak of the pandemic. Patients will be eligible for inclusion if they meet the current clinical diagnostic criteria of 1. Fever (pyrexia =38°C) or a history of fever and 2. Influenza-like illness (two or more of cough, sore throat, rhinorrhoea, limb or joint pain, headache, vomiting or diarrhoea) or 3. Severe and/or life-threatening illness suggestive of an infectious process or 4. If they meet any future clinical diagnostic criteria recommended by the Department of Health. The assessing clinician will determine eligibility and complete the data collection form if the patient is considered to have suspected pandemic influenza.

Exclusion criteria

Exclusion criteria: We will not attempt to retrospectively apply the clinical diagnostic criteria and exclude patients who appear to have been inappropriately included. Patients will only be excluded if they request exclusion from the study.

Design outcomes

Primary

MeasureTime frame
Patients will be followed-up until 30 days after attendance by hospital record review.. 1. Patients who die or require respiratory, cardiovascular or renal support they will be defined as having an adverse outcome. 2. If they survive to 30 days without requiring respiratory, cardiovascular or renal support they will be defined as having no adverse outcome. 3. If a severe pandemic leads to hospital resources being overwhelmed we will categorise patients as having an adverse outcome if they were deemed to have needed respiratory, cardiovascular or renal support but were denied this due to lack of resources. At day 30 the anonymous data will be entered into the database.

Secondary

MeasureTime frame
1. Record whether patients are treated with antiviral agents or antibiotics 2. The length and location of any hospital stay

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 18, 2026